Hikma Pharmaceuticals Plc Hikma Analyst and Investor Call
February 10 2016 - 5:38AM
RNS Non-Regulatory
TIDMHIK
Hikma Pharmaceuticals Plc
10 February 2016
Hikma to host investor and analyst conference call
London, 10 February 2016 - Hikma Pharmaceuticals PLC ("Hikma")
(LSE: HIK) (NASDAQ Dubai: HIK) (OTC: HKMPY), (rated Ba1 Moody's /
BB+ S&P, both stable), the fast growing pharmaceuticals
company, announces that Hikma management will host a conference
call for investors and analysts today at 12:30pm UK time to discuss
the revised terms for its previously announced acquisition of
Roxane Laboratories.
The conference call can be accessed by dialling +44 (0)20 3139
4830, and the participant PIN code is 25497247#. An audio replay of
the conference call will also be made available approximately two
hours after the conclusion of the call. The audio replay can be
accessed by dialling +44 (0)20 3426 2807 and entering the PIN code
668223#.
Said Darwazah, Chairman and Chief Executive Officer of Hikma,
and Khalid Nabilsi, Chief Financial Officer of Hikma, will host the
call.
-- ENDS --
Enquiries
Hikma Pharmaceuticals PLC
Susan Ringdal, VP Corporate Strategy and Investor Relations +44
(0)20 7399 2760/ +44 7776 477050
Zeena Murad, Investor Relations Manager +44 (0)20 7399 2768/ +44
7771 665277
FTI Consulting
Ben Atwell/ Matthew Cole +44 (0)20 3727 1000
About Hikma
Hikma Pharmaceuticals PLC is a fast growing multinational group
focused on developing, manufacturing and marketing a broad range of
both branded and non-branded generic and in-licensed products.
Hikma operates through three businesses: "Branded", "Injectables"
and "Generics", based principally in the Middle East and North
Africa ("MENA"), where it is a market leader, the United States and
Europe. In 2014, Hikma achieved revenues of US$1,489 million and
profit attributable to shareholders of US$299 million.
This information is provided by RNS
The company news service from the London Stock Exchange
END
NRAURORRNBAUAAR
(END) Dow Jones Newswires
February 10, 2016 05:38 ET (10:38 GMT)
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Jun 2024 to Jul 2024
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Jul 2023 to Jul 2024